These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16496669)

  • 1. [Preparation of ondansetron hydrochloride osmotic pump tablets and their in vitro drug release].
    Zheng HS; Bi DZ
    Yao Xue Xue Bao; 2005 Dec; 40(12):1080-4. PubMed ID: 16496669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach.
    Gundu R; Pekamwar S; Shelke S; Shep S; Kulkarni D
    Drug Dev Ind Pharm; 2020 Mar; 46(3):343-355. PubMed ID: 31937128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
    Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ
    Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and in vitro release characteristics of pulsed-release tablets of Apocynum venetum].
    Yang H; Xie F; Yang Y; Luo Y
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1427-30. PubMed ID: 22779170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin complex osmotic tablet for glipizide delivery.
    Gan Y; Pan W; Wei M; Zhang R
    Drug Dev Ind Pharm; 2002 Sep; 28(8):1015-21. PubMed ID: 12378956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of atenolol monolithic osmotic pump tablets].
    Liu LX; Che BJ; Xu Q
    Yao Xue Xue Bao; 2006 May; 41(5):457-60. PubMed ID: 16848324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A squeeze-type osmotic tablet for controlled delivery of nifedipine.
    Park JS; Shin JH; Lee DH; Kim MS; Rhee JM; Lee HB; Khang G
    J Biomater Sci Polym Ed; 2008; 19(1):31-45. PubMed ID: 18177552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
    Nokhodchi A; Momin MN; Shokri J; Shahsavari M; Rashidi PA
    Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
    Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
    Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice.
    Lin YK; Ho HO
    J Control Release; 2003 Apr; 89(1):57-69. PubMed ID: 12695063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
    Liu L; Xu X
    Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of prazosin hydrochloride from osmotic pump system prepared by coating the core tablet with an indentation.
    Liu L; Wang J; Zhu S
    Drug Deliv; 2007 Apr; 14(4):219-24. PubMed ID: 17497354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium.
    Ramakrishna N; Mishra B
    Drug Dev Ind Pharm; 2002 Apr; 28(4):403-12. PubMed ID: 12056533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sandwiched osmotic pump tablet for controlled release of water-insoluble drug].
    Liu LX; Khang G; Rhee JM; Lee HB
    Yao Xue Xue Bao; 2003 Aug; 38(8):620-3. PubMed ID: 14628456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.